Stock Scorecard



Stock Summary for Sanofi (SNY) - $47.78 as of 11/20/2024 8:43:52 PM EST

Total Score

12 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for SNY

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SNY

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SNY

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for SNY

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for SNY (78 out of 90)

Stock Price Rating (Max of 10) 8
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 9
Book Value to Price (Max of 10) 8
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 6
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 7

Latest News for for SNY

Snowflake ( SNOW ) Q3 2025 Earnings Call Transcript 11/21/2024 4:30:00 AM
Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines? - Moderna ( NASDAQ:MRNA ) , GSK ( NYSE:GSK ) 11/20/2024 1:41:00 PM
Sanofi: Information concerning the total number of voting rights and shares - October 2024 11/20/2024 1:11:00 PM
Regeneron Pharmaceuticals's Options: A Look at What the Big Money is Thinking - Regeneron Pharmaceuticals ( NASDAQ:REGN ) 11/19/2024 5:15:00 PM
FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria 11/18/2024 8:00:00 PM
FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria 11/18/2024 8:00:00 PM
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer 11/18/2024 1:30:00 PM
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer 11/18/2024 12:30:00 PM
BioNTech's Options: A Look at What the Big Money is Thinking - BioNTech ( NASDAQ:BNTX ) 11/15/2024 8:01:00 PM
European And US Vaccine Stocks Are Under Pressure - Here's WHy - GSK ( NYSE:GSK ) , Pfizer ( NYSE:PFE ) 11/15/2024 4:21:00 PM

Financial Details for SNY

Company Overview

Ticker SNY
Company Name Sanofi
Country USA
Description Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2024
Next Earnings Date N/A

Stock Price History

Last Day Price 47.78
Price 4 Years Ago 41.66
Last Day Price Updated 11/20/2024 8:43:52 PM EST
Last Day Volume 1,261,379
Average Daily Volume 2,076,362
52-Week High 58.97
52-Week Low 45.22
Last Price to 52 Week Low 5.66%

Valuation Measures

Trailing PE 25.40
Industry PE 22.60
Sector PE 40.32
5-Year Average PE 11.80
Free Cash Flow Ratio 17.63
Industry Free Cash Flow Ratio 12.03
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 1.00
Total Cash Per Share 2.71
Book Value Per Share Most Recent Quarter 58.10
Price to Book Ratio 1.57
Industry Price to Book Ratio 5.31
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 2.51
Industry Price to Sales Ratio Twelve Trailing Months 11.82
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 5
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 2,507,160,000
Market Capitalization 119,792,104,800
Institutional Ownership N/A

Dividends

Ex-Dividend Date 5/9/2024
Last Dividend Amount 1.90
Current Dividend Amount 2.04
Total Years Dividend Increasing 1
Trailing Annual Dividend Rate 2.04
Trailing Annual Dividend Yield 4.26%
Forward Annual Dividend Rate 2.08
Forward Annual Dividend Yield 4.36%
5-Year Dividend Payments Count 6
3-Year Average Dividend Yield 3.96%
5-Year Average Dividend Yield 3.77%
1-Year Dividend Growth Rate Percentage -7.04%
3-Year Dividend Growth Rate Percentage -0.75%
5-Year Dividend Growth Rate Percentage 2.23%
All-Time Dividend Growth Rate Percentage 8.20%
Dividend Payout Ratio 106.67%

Income Statement

Quarterly Earnings Growth YOY 11.50%
Annual Earnings Growth -35.49%
Reported EPS 12 Trailing Months 1.91
Reported EPS Past Year 3.47
Reported EPS Prior Year 5.77
Net Income Twelve Trailing Months 7,031,000,000
Net Income Past Year 5,400,000,000
Net Income Prior Year 8,371,000,000
Quarterly Revenue Growth YOY 11.50%
5-Year Revenue Growth 5.23%
Operating Margin Twelve Trailing Months 0.29

Balance Sheet

Total Cash Most Recent Quarter 6,795,000,000
Total Cash Past Year 8,710,000,000
Total Cash Prior Year 12,736,000,000
Net Cash Position Most Recent Quarter -5,708,000,000
Net Cash Position Past Year -5,637,000,000
Long Term Debt Past Year 14,347,000,000
Long Term Debt Prior Year 14,857,000,000
Total Debt Most Recent Quarter 12,503,000,000
Equity to Debt Ratio Past Year 0.84
Equity to Debt Ratio Most Recent Quarter 0.85
Total Stockholder Equity Past Year 74,040,000,000
Total Stockholder Equity Prior Year 74,784,000,000
Total Stockholder Equity Most Recent Quarter 72,690,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 4,083,000,000
Free Cash Flow Per Share Twelve Trailing Months 1.63
Free Cash Flow Past Year 7,005,000,000
Free Cash Flow Prior Year 8,325,000,000

Options

Put/Call Ratio 0.05
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -1.32
MACD Signal -1.03
20-Day Bollinger Lower Band 48.37
20-Day Bollinger Middle Band 53.91
20-Day Bollinger Upper Band 59.45
Beta 0.44
RSI 23.84
50-Day SMA 49.78
150-Day SMA 47.37
200-Day SMA 46.59

System

Modified 11/19/2024 1:04:21 PM EST